Sun Pharmaceutical Industries Ltd. (SUNP:IN) PT Lowered to INR1,875 at KotakKotak analyst Alankar Garude lowered the price target on Sun Pharmaceutical Industries Ltd. (SUNP:IN) to INR1,875.00 (from INR1,900.00) while maintaining a Add (2) rating.
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Unknown Analyst
Geojit Research
Not Ranked
Geojit Research
₹1,899
Buy
9.76%
Upside
Reiterated
02/17/26
Sun Pharmaceutical Industries Limited (SUNPHARMA) Gets a Buy from Geojit Research
Unknown Analyst
ICICI Securities
Not Ranked
ICICI Securities
₹1,910
Buy
10.40%
Upside
Reiterated
02/01/26
ICICI Securities Sticks to Their Buy Rating for Sun Pharmaceutical Industries Limited (SUNPHARMA)
Unknown Analyst
Motilal Oswal
Not Ranked
Motilal Oswal
₹1,940
Buy
12.13%
Upside
Reiterated
01/31/26
Motilal Oswal Sticks to Its Buy Rating for Sun Pharmaceutical Industries Limited (SUNPHARMA)
Sun Pharmaceutical Industries Ltd. (SUNP:IN) PT Lowered to INR1,875 at KotakKotak analyst Alankar Garude lowered the price target on Sun Pharmaceutical Industries Ltd. (SUNP:IN) to INR1,875.00 (from INR1,900.00) while maintaining a Add (2) rating.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Copying Bansi Desai's trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +2.38% per trade.
Copying Kunal Dhamesha's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +11.18% per trade.
Copying Bansi Desai's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +13.30% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
SUNPHARMA Analyst Recommendation Trends
Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
0
0
0
0
0
Buy
2
3
3
2
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
2
3
3
2
0
In the current month, SUNPHARMA has received 0Buy Ratings, 0Hold Ratings, and 0Sell Ratings. SUNPHARMA average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.
SUNPHARMA Stock Forecast FAQ
What is IN:SUNPHARMA’s average 12-month price target, according to analysts?
Currently, no data Available
What is IN:SUNPHARMA’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IN:SUNPHARMA, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Sun Pharmaceutical Industries Limited a Buy, Sell or Hold?
Currently, no data Available
What is Sun Pharmaceutical Industries Limited’s share price target?
Currently, no data Available
What do analysts say about Sun Pharmaceutical Industries Limited?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Sun Pharmaceutical Industries Limited?
To buy shares of IN:SUNPHARMA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.